NIH/National Eye Institute
Strategy confirmed to help doctors determine when to treat retinopathy of prematurity
Published in Medical Devices and Surgical Technology Week, May 2nd, 2010
These long-term results of the Early Treatment for Retinopathy of Prematurity (ETROP) study confirm that the visual benefit of early treatment for selected infants continues through 6 years of age. The research, published April 12 online in Archives of Ophthalmology, was supported by the National Eye Institute (NEI), part of the National Institutes of Health.
"This study has set the standard of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Johns Hopkins Medical Institutions
'Love handles' repurposed for breast reconstruction in women without enough belly fat - University of Cincinnati Academic Health Center
Researchers quantify benefits of minimally invasive removal of hard-to-reach tumors - Cardica, Inc.
First Peer-Reviewed Publication Validating Cardica's C-Port Systems Efficacy in Beating-Heart Bypass Procedures Using Arterial Grafts - Sudden Cardiac Arrest SCA Foundation
Study Shows Bystander Use of AEDs Saves Lives - TYRX, Inc.
New Anti-Bacterial Device Helps Reduce Infections Associated with Pacemaker and Defibrillator Implantation* - Abdominal Hysterectomy
Research from Mayo Clinic broadens understanding of abdominal hysterectomy - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
